Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Clinical and Experimental Medicine (Testo stampato)

• Publication date

  2013-11-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s10238-012-0201-xPMID 22828727
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of autophagy in temozolomide treated malignant gliomas

  2011cited by this paper
• Development and evaluation of human AP endonuclease inhibitors in melanoma and glioma cell lines

  2011cited by this paper
• N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide.

  2011cited by this paper
• Acquired Resistance to Temozolomide in Glioma Cell Lines: Molecular Mechanisms and Potential Translational Applications

  2010cited by this paper
• Clinical Significance of Molecular Biomarkers in Glioblastoma

  2010cited by this paper
• Changes of the O6-methylguanine-DNA methyltransferase promoter methylation and MGMT protein expression after adjuvant treatment in glioblastoma.

  2010cited by this paper
• Diversity of DNA damage response of astrocytes and glioblastoma cell lines with various p53 status to treatment with etoposide and temozolomide

  2009cited by this paper
• Going Ape as an Approach to Cancer Therapeutics

  2009cited by this paper
• DNA repair and cancer stem-like cells--potential partners in glioma drug resistance?

  2008cited by this paper
• Base excision repair and its role in maintaining genome stability.

  2008cited by this paper
• Contribution of DNA repair mechanisms to determining chemotherapy response in high-grade glioma.

  2008cited by this paper
• Targeting base excision repair for chemosensitization.

  2008cited by this paper
• Promoter Methylation and Polymorphisms of the MGMT Gene in Glioblastomas: A Population-Based Study

  2008cited by this paper
• Base Excision Repair and its Role in Maintaining Genome Stability

  2008cited by this paper
• Manipulation of Base Excision Repair to Sensitize Ovarian Cancer Cells to Alkylating Agent Temozolomide

  2007cited by this paper
• Genetic pathways to primary and secondary glioblastoma.

  2007cited by this paper
• A Ubiquitin-binding Motif in the Translesion DNA Polymerase Rev1 Mediates Its Essential Functional Interaction with Ubiquitinated Proliferating Cell Nuclear Antigen in Response to DNA Damage*

  2007cited by this paper
• A unified view of base excision repair: lesion-dependent protein complexes regulated by post-translational modification.

  2007cited by this paper
• Triazene compounds: mechanism of action and related DNA repair systems.

  2007cited by this paper
• MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.

  2007cited by this paper
• Malignant astrocytic glioma: genetics, biology, and paths to treatment.

  2007cited by this paper
• The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.

  2007cited by this paper
• Targeted cancer therapies based on the inhibition of DNA strand break repair

  2007cited by this paper
• Monoubiquitination of Proliferating Cell Nuclear Antigen Induced by Stalled Replication Requires Uncoupling of DNA Polymerase and Mini-chromosome Maintenance Helicase Activities*

  2006cited by this paper
• O6‐methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells

  2006cited by this paper
• Clonogenic assay of cells in vitro

  2006cited by this paper
• DNA repair inhibition: a selective tumour targeting strategy.

  2005cited by this paper
• Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence.

  2005cited by this paper
• Therapeutic impact of methoxyamine: blocking repair of abasic sites in the base excision repair pathway.

  2004cited by this paper
• Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells.

  2004cited by this paper
• Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells

  2004cited by this paper
• Blockage of abasic site repair enhances antitumor efficacy of 1,3-bis-(2-chloroethyl)-1-nitrosourea in colon tumor xenografts.

  2003cited by this paper
• Proliferating cell nuclear antigen (PCNA): a dancer with many partners

  2003cited by this paper
• Pharmacological strategies to increase the antitumor activity of methylating agents.

  2002cited by this paper
• Base excision repair as a therapeutic target in colon cancer.

  2002influential reference
• Involvement of DNA polymerase beta in protection against the cytotoxicity of oxidative DNA damage.

  2002cited by this paper
• Multifaceted resistance of gliomas to temozolomide.

  2002cited by this paper
• Temozolomide: a novel oral alkylating agent

  2001cited by this paper
• p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells.

  2001cited by this paper
• Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.

  2001cited by this paper
• Apurinic/apyrimidinic endonuclease activity is elevated in human adult gliomas.

  2001cited by this paper
• Chromatin-bound PCNA complex formation triggered by DNA damage occurs independent of the ATM gene product in human cells.

  2001cited by this paper
• Mammalian DNA beta-polymerase in base excision repair of alkylation damage.

  2001cited by this paper
• Methoxyamine potentiates DNA single strand breaks and double strand breaks induced by temozolomide in colon cancer cells.

  2001cited by this paper
• The mechanism of switching among multiple BER pathways.

  2001cited by this paper
• Mammalian DNA β-polymerase in base excision repair of alkylation damage

  2001cited by this paper
• Session 1 multiple pathways for DNA base excision repair

  2001cited by this paper
• Apurinic/apyrimidinic endonuclease expression in pediatric yolk sac tumors.

  2000cited by this paper
• Repair of O(6)-alkylguanine by alkyltransferases.

  2000cited by this paper
• Repair of O6-alkylguanine by alkyltransferases

  2000cited by this paper
• Cleavage of Substrates with Mismatched Nucleotides by Flap Endonuclease-1

  1999cited by this paper
• Frequent Co‐Alterations of TP53, p16/CDKN2A, p14ARF, PTEN Tumor Suppressor Genes in Human Glioma Cell Lines.

  1999cited by this paper
• O6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy.

  1999cited by this paper
• Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents.

  1999cited by this paper
• New treatment strategies for malignant gliomas.

  1999cited by this paper
• Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignancies.

  1999cited by this paper
• Biology and treatment of malignant glioma.

  1998cited by this paper
• Chemotherapy of brain tumors.

  1998cited by this paper
• Mammalian base excision repair and DNA polymerase beta.

  1998cited by this paper
• Fen1 expression: a novel marker for cell proliferation

  1998cited by this paper
• Second pathway for completion of human DNA base excision‐repair: reconstitution with purified proteins and requirement for DNase IV (FEN1)

  1997cited by this paper
• Role of O6-methylguanine-DNA methyltransferase in resistance of human brain tumor cell lines to the clinically relevant methylating agents temozolomide and streptozotocin.

  1996cited by this paper
• Contribution of O6‐methylguanine‐DNA methyltransferase to monofunctional alkylating‐agent resistance in human brain tumor—derived cell lines

  1995cited by this paper
• Mutagenic processing of ethylation damage in mammalian cells: the use of methoxyamine to study apurinic/apyrimidinic site-induced mutagenesis.

  1993cited by this paper
• Processing in vitro of an abasic site reacted with methoxyamine: a new assay for the detection of abasic sites formed in vivo.

  1991cited by this paper
• A simple technique for quantitation of low levels of DNA damage in individual cells.

  1988cited by this paper
• A new approach to the study of the base-excision repair pathway using methoxyamine.

  1985cited by this paper
• Reaction of apurinic/apyrimidinic sites with [14C]methoxyamine. A method for the quantitative assay of AP sites in DNA.

  1983cited by this paper

• Proinflammatory macrophage secretome enhances temozolomide sensitivity in glioblastoma via pSTAT3-mediated downregulation of DNA repair enzymes

  2025cites this paper
• The hidden elephant: Modified abasic sites and their consequences.

  2025cites this paper
• Bypass of Methoxyamine-Adducted Abasic Sites by Eukaryotic Translesion DNA Polymerases

  2025cites this paper
• Repurposing the Antihypertensive Agent Hydralazine As an Inhibitor of the Base Excision Repair Enzyme APE1.

  2024cites this paper
• Targeting APE1: Advancements in the Diagnosis and Treatment of Tumors.

  2024cites this paper
• How to sensitize glioblastomas to temozolomide chemotherapy: a gap-centered view

  2024cites this paper
• Temozolomide resistance mechanisms: unveiling the role of translesion DNA polymerase kappa in glioblastoma spheroids in vitro

  2024cites this paper
• Ultrafast Reaction of the Drug Hydralazine with Apurinic/Apyrimidinic Sites in DNA Gives Rise to a Stable Triazolo[3,4-a]phthalazine Adduct.

  2024cites this paper
• Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT.

  2024cites this paper
• Anthracyclines React with Apurinic/Apyrimidinic Sites in DNA.

  2023cites this paper
• Miscoding and DNA Polymerase Stalling by Methoxyamine-Adducted Abasic Sites.

  2022cites this paper
• The Role of 8-oxoG Repair Systems in Tumorigenesis and Cancer Therapy

  2022cites this paper
• DNA Repair Pathways in Cancer Therapy and Resistance

  2021cites this paper
• Versatile cell-based assay for measuring DNA alkylation damage and its repair

  2021cites this paper
• Anti-Proliferative Effects of E2F1 Suppression in Glioblastoma Cells

  2021cites this paper
• Therapeutic approaches to overcome temozolomide resistance in glioblastoma

  2021cites this paper
• In vitro biomimetic models for glioblastoma-a promising tool for drug response studies.

  2021cites this paper
• Targeting Base Excision Repair in Cancer: NQO1-Bioactivatable Drugs Improve Tumor Selectivity and Reduce Treatment Toxicity Through Radiosensitization of Human Cancer

  2020cites this paper
• The redox function of apurinic/apyrimidinic endonuclease 1 as key modulator in photodynamic therapy.

  2020cites this paper
• Restoration of Temozolomide Sensitivity by PARP Inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair

  2020cites this paper
• Combination treatment for glioblastoma with temozolomide, DFMO and radiation.

  2019cites this paper
• Mitigating Temozolomide Resistance in Glioblastoma via DNA Damage-Repair Inhibition

  2019cites this paper
• Interaction of Functionalized Naphthalenophanes with Abasic Sites in DNA: DNA Cleavage, DNA Cleavage Inhibition, and Formation of Ligand-DNA Adducts.

  2019cites this paper
• Advances in therapeutic targeting of the DNA damage response in cancer.

  2018cites this paper
• Synthesis, characterization and antitumor activity of palladium(II) complexes of imidazolidine-2-thione

  2017cites this paper
• A novel class of chemicals that react with abasic sites in DNA and specifically kill B cell cancers

  2017cites this paper
• Corilagin Induces High Levels of Apoptosis in the Temozolomide-Resistant T98G Glioma Cell Line.

  2017cites this paper
• Human Apurinic/Apyrimidinic Endonuclease (APE1) Is Acetylated at DNA Damage Sites in Chromatin, and Acetylation Modulates Its DNA Repair Activity

  2016cites this paper
• HEB silencing induces anti-proliferative effects on U87MG cells cultured as neurospheres and monolayers.

  2016cites this paper
• In vitro effects of photodynamic therapy induced by chloroaluminum phthalocyanine nanoemulsion.

  2016cites this paper
• Development Of A Novel Class Of Chemicals For Labeling Abasic Sites In Cellular Dna And Killing Cancer Cells

  2016cites this paper
• Anticancer activity against glioblastoma cell lines by compounds present in algae, alone and in combination with anticancer drugs

  2016cites this paper
• Biochemical effect of a histidine phosphatase acid (phytase) of Aspergillus japonicus var. Saito on performance and bony characteristics of broiler

  2016cites this paper
• APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.

  2015cites this paper
• Characterisation of CTR-17 and CTR-20, novel chalcone derivatives that inhibit tubulin polymerisation activity

  2015cites this paper
• The Antiproliferative and Pro-apoptotic Effects of Methoxyamine on Pediatric Medulloblastoma Cell Lines Exposed to Ionizing Radiation and Chemotherapy.

  2015cites this paper
• Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone

  2015cites this paper
• Efficient inhibition of human AP endonuclease 1 (APE1) via substrate masking by abasic site-binding macrocyclic ligands.

  2015cites this paper
• Indoleamine 2,3-dioxygenase confers resistance to chemotherapy and γ radiation to cancer cells, independent of direct immune involvement

  2014influential citation
• Base Excision Repair Inhibition by Methoxyamine Impairs Growth and Sensitizes Osteosarcoma Cells to Conventional Treatments

  2014cites this paper
• INFLUÊNCIA DO GENE APE1/REF-1 NAS RESPOSTAS CELULARES DAS LINHAGENS DE GLIOBLASTOMA AO QUIMIOTERÁPICO TEMOZOLOMIDA

  2013cites this paper
• Chemoresistance in Glioma

  2013cites this paper
• Cisplatin associated with LY294002 increases cytotoxicity and induces changes in transcript profiles of glioblastoma cells

  2013cites this paper
• Role of Tyrosyl-DNA Phosphodiesterase I (TDP1) as a Prognostic and Predictive Factor in Malignant Glioma

  2013cites this paper
• Establishing the validity of glycoursodeoxycholic acid as a coadjuvant of temozolomide therapy in gliomas

  2012cites this paper